Effects of Gypsophila on Airway Inflammation in Guinea pig model of ovalbumin‐induced Asthma

Year : 2024 | Volume :14 | Issue : 01 | Page : 17-23

Yong-Mi Ri

Chol-Jin Jang

Yong-Uk Ri

Myong-Song Kim

  1. Researcher Pyongyang University of Medical Sciences Pyongyang Korea
  2. Researcher Pyongyang University of Medical Sciences Pyongyang Korea
  3. Researcher Pyongyang University of Medical Sciences Pyongyang Korea
  4. Researcher Pyongyang University of Medical Sciences Pyongyang Korea


To look at how Gypsophlia (GSP) affects airway inflammation in a model of ovalbumin-induced asthma in guinea pigs (OVA).Methods: Using a random number table, sixty healthy female guinea pigs were split into six groups, each consisting of ten rats: the normal control, OVA, and GSP (0.45, 0.9, 1.8, and 3.6 g/kg). The ovalbumin and lipopolysaccharide sensitization approach was used to create the OVA guinea pig model. The GSP groups received oral GSP (0.9, 1.86g/kg) for 20 days, respectively, at 0.5 h prior to each challenge, whereas the other two groups received an equivalent volume of normal saline. Methacholine aerosol inhalation was done and airway reactivity was assessed 24 hours after the last challenge. The fluid known as bronchoalveolar lavage (BALF) was extracted. For differential counts and total white blood cell counts, Wright-Giemsa staining was employed. Interleukin (IL)-17 and IL-10 levels were measured using an enzyme-linked immunosorbent assay. Results: The airway responsiveness of the OVA group was significantly higher than the normal control group (P<0.05), while those in the GSP groups were significantly lower than the OVA group (P<0.05). The neutrophil and eosinophil counts in the GSP groups were significantly lower than the NA group (P<0.05), and those in the GSP group were significantly lower than the DXM group (P<0.05). There were a large number of peribronchiolar and perivascular inflammatory cells infiltration in the NA group. The airway inflammation in the GSP groups were significantly alleviated than the OVA group. Compared with the normal control group, the IL-17 level in BALF was significantly increased and the IL-10 level in BALF was significantly decreased in the OVA group (P<0.05). GSP treatment significantly decreased IL-17 levels and increased IL-10 levels compared with the OVA group (P<0.05), and the changes in the above indices were more significant in the GSP group (P<0.05). Conclusion: GSP could alleviate the airway inflammation in the OVA –guinea pigs model through increasing the IL-10 level and decreasing the IL-17 level.

Keywords: Gypsophila, Ovalbumin-induced asthma, Airway inflammation, Cytokine, Asthma.

[This article belongs to Research & Reviews: A Journal of Pharmacology(rrjop)]

How to cite this article: Yong-Mi Ri, Chol-Jin Jang, Yong-Uk Ri, Myong-Song Kim. Effects of Gypsophila on Airway Inflammation in Guinea pig model of ovalbumin‐induced Asthma. Research & Reviews: A Journal of Pharmacology. 2024; 14(01):17-23.
How to cite this URL: Yong-Mi Ri, Chol-Jin Jang, Yong-Uk Ri, Myong-Song Kim. Effects of Gypsophila on Airway Inflammation in Guinea pig model of ovalbumin‐induced Asthma. Research & Reviews: A Journal of Pharmacology. 2024; 14(01):17-23. Available from: https://journals.stmjournals.com/rrjop/article=2024/view=136829


  1. Chung MJ, Pandey  RP,  Choi  JW, Sohng  JK,  Choi  DJ, & Park YI, et al. Inhibitory effects of kaempferol‐3‐O‐rhamnoside on ovalbumin‐induced lung inflammation in a mouse model of allergic asthma, International Immunopharmacology 2015 ;25:302–310.
  2. Frieri   Advances in the understanding of allergic asthma. Allergy & Asthma Proceedings 2007;28:614–619.
  3. Mcculloch M, See  C,  Shu  X,  Broffman  M,  Kramer  A,  Fan  W, Colford   Astragalus‐based chinese herbs and platinum‐based chemotherapy for advanced non–small‐cell lung cancer:Meta‐analysis of randomized trials. Journ al of Clinical Oncology 2005;24:419–430.
  4. Jin H, Wang  L,  Li  B,  Cai C, Ye  J,  Xia  J, &  Ma  Astragaloside IV Ameliorates Airway Inflammation in an Established Murine Model of Asthma by Inhibiting the mTORC1 YANG ANd WANG 7Signaling Pathway. Evidence‐Based Complementray and Alternative Medicine 2017:1–10.
  5. Li L,  Hou  X,  Xu  R,  Liu  C,  &  Tu   Research review on the pharmacological effects of astragaloside IV. Fundamental & Clinical Pharmacology 2017;31:17–36.
  6. Mcgrath KW, Icitovic N, Boushey HA, Lazarus SC, Sutherland ER, Chinchilli VM et al. A large subgroup of mild-to-moderate asthma is persistently noneosinophili-c. Am J Respir Crit Care Med . 2012;185:612-619.
  7. Zhang YX, Nong GM, Liao J, Jiang M, Liang XA, Liu J, et al. Application of induced sputum cytology analysis for childhood asthma subtype. Chin J Appl Clin Pediatr 2010;25:129-132.
  8. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung F, Barnes PJ, et al. Neutrophilic in flammation in severe persistent asthma. Am J Respir Crit Care Med. 2012;160:1532-1539.
  9. Zhao Y, Yang J, Gao YD, Guo W. Th17 immunity in patients with allergic asthma. Intern Arch Allergy Immun 2010;151:297-307.
  10. Zhou C, Yin KS, Chen JH, Shi Y. Changes of the ratio of T helper 17 cells and the level of IL-17 in bronchial asthmatic guinea pigs. J Nanjing Med Univ (Nat Sci) 2009;29:109-112.
  11. Zhang XP, Jiang J, Cheng QH, Ye Q, Li WJ, Zhu H, et al. Protective effects of ligustrazine, kakonein and panax notoginsenoside on the small intestine andimmune organs of rats with severe acute pancreatitis. Hepatobiliary Pancreatic Dis Int 2011;10:632-637.
  1. Liu RT, Li BZ. Clinical observation of Ligustrazine Injection adjuvant therapy 36 cases infant with bronchial asthma. China Med Herald (Chin) 2011;8:66-68.
  2. Zhu W, Tian H. The treatment of 38 children with asthma in acute stage by tetrame-thylpyrazine and small dosages of tripterygioside. West J Tradit Chin Med (Chin) 2015;28:102-104.
  3. Xie H, Sun SH. The observation of azithromycin combined ligustrazine on the treatment of glucocorticoid resistance type of asthma. Modern J Integr Tradit Chin West Med (Chin) 2003;13:987-988.
  4. Jiang H, Chen X, Wang JY, Xue YF. Effect of ligustrazine on Th17 cell and balance of Th17/Treg in asthma model mouse. Chin J Immun 2014;10:1339-1343.
  1. Qiu YY, Zhu JX,  Bian  T,  Gao  F,  Qian  XF,  Du  Q,  Yu MH.  Protective effects of astragaloside IV against ovalbumin‐induced lung inflammation are regulated/mediated by T‐bet/GATA‐3. Pharmacology 2014;94:51–59.
  2. Wang YJ, Zhu HZ, Kong XC, Lu L, Liu L, Zhang Y, et al. Observation of the effec-t of ligustrazine on improving the airway of asthmatic rats. Chin Tradit Patent Med (Chin) 2014;36:834-837.
  3. Wilson RH, Whitehead GS, Nakano H, Free ME, Kolls JK, Cook DN, et al. Allergic sensitization through the airway primes Th17-dependent neutrophilia and airwayhyperresponsiveness. Am J  Respir   Critic  Care  Med . 2009;180:20-730.
  4. Liu XW, Jiang M, Nong GM, Liu HY, Peng F. To establish a guinea pigs model of neutrophilic asthma and research the airway hyperreactivity. Chin J Asthma (Electronic Version) 2013;7:151-158.
  5. Wei Y, Luo QL, Sun J, Chen MX, Liu F, Dong JC, et al. Bu-ShenYi-Qi Formulae suppress chronic airway in fl ammation and regulate Th17/Treg imbalance in the murine ovalbumin asthma model. J Ethnopharmacol 2015;164:368-377.
  6. Mckinley L, Alcorn JF, Peterson A, Dupont RB, Kapadia S, Logar Alision, et al. Th17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in guinea pigs. J. Immun 2008;181:4089-4097.
  7. Zhang LQ. Clinical observation of pidotimod and ligustrazine in children with bronchial asthma. Shaanxi Med J (Chin) 2013;42:355-356.
  8. Che XW, Wang H, Zhang Y, Wang W. Effect of Ligustrazine Injection on levels of interleukin-4 and interferon-γ in patients with bronchial asthma. Chin J Integr Med 2008;14:217-220.
  9. Pelaia G, Vatrella A, Maselli R. The potential of biologics for the treatment of asthma. Nature Rev Drug Discov 2012;11:958-972.
  10. Qiu YY, Zhang YW, Qian XF, Bian T. MiR-371, miR-138, miR-544, miR-145, and miR-214 could modulate Th1/Th2 balance in asthma through the combinatorial regulation of Runx3. Am J Transl Res 2017;9:3184-3199.

Regular Issue Subscription Original Research
Volume 14
Issue 01
Received February 12, 2024
Accepted March 7, 2024
Published March 29, 2024